Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
Karo Bio AB
Download detailed PDF Members: Karo Bio is an innovative drug discovery and development company specializing in nuclear receptors for the development of novel pharmaceuticals. The company has a strong project portfolio primarily targeting metabolic diseases such as diabetes, obesity, atherosclerosis and dyslipidemia. Karo Bio has expanded from being a drug discovery company by adding in-house preclinical development resources and expertise for clinical development. The company also has two strategic collaborations with international pharmaceutical companies for developing innovative therapies for the treatment of common diseases. Karo Bio has been listed on the Stockholm stock exchange since 1998
This page has been viewed 213 times since April 2007, the link to the organisation's website has been followed 32 times Search for more companies in Novum Search for more companies in Huddinge This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Karo Bio AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|